A new approach to enhance bioavailability of biologically active peptides: conjugation of a δ opioid agonist to β-cyclodextrin

  • Maria K. Hristova-Kazmierski
  • , P. Horan
  • , P. Davis
  • , H. I. Yamamura
  • , T. Kramer
  • , R. Horvath
  • , W. M. Kazmierski
  • , F. Porreca
  • , Victor J. Hruby

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

The cyclic δ opioid against [p-I-Phe4]DPDPE, 1, was conjugated to mono-6-amino-permethyl-β-cyclodextrin at the C-terminus to improve the bioavailability of 1. In the rat brain building assay, the conjugate 8 showed an IC50 = 134 nM vs. a δ ligand and IC50 > 10 μM at the μ receptor, making it less potent and selective than 1. However, 8 shows antinociceptive properties (i.v.) in the mouse tail flick test and prolonged activity.

Original languageEnglish (US)
Pages (from-to)831-834
Number of pages4
JournalBioorganic and Medicinal Chemistry Letters
Volume3
Issue number5
DOIs
StatePublished - May 1993

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Fingerprint

Dive into the research topics of 'A new approach to enhance bioavailability of biologically active peptides: conjugation of a δ opioid agonist to β-cyclodextrin'. Together they form a unique fingerprint.

Cite this